David Jang Author
Subjects of specialization
Affiliation
Cardiovascular drug;, LD50; , Dihydropyridine
New York University School of Medicine, USA
David Jang, New York University School of Medicine, USA, The Novel Development of an Experimental Model of Dihydropyridine Calcium Channel Blocker Poisoning using Intravenous Amlodipine
Research Article Subscription
Author(s): David Jang, Sean Donovan, Theodore Bania, Lewis Nelson, Robert Hoffman and Jason Chu
The Novel Development of an Experimental Model of Dihydropyridine Calcium Channel Blocker Poisoning using Intravenous Amlodipine
Cardiovascular drug poisoning remains a leading cause of fatality. Within this class, calcium channel blockers(CCBs) account for the majority of deaths. CCBs are typically categorized as dihydropyridines (i.e. amlodipine or nifedipine) versus the non-dihydropyridine (i.e. verapamil and diltiazem) which are the most potent and once considered the CCB type responsible for all CCB-related deaths. Most recently, dihydropyridine deaths have incr... view moreĀ»